Company intelligence / Profile preview

Path Fertility

Salt Lake City, Utah, United Statespathfertility.com ↗

Ownership: Private
Development stage: Commercial

Overview

Path Fertility’s lead product SpermQT has been validated on over 2,000 semen samples with an ~84% sensitivity in predicting the need for IVF treatment. The SPOT study—a pivotal clinical trial—has reached full enrollment with interim results expected soon. The test has demonstrated it can identify subfertile men missed by standard semen analysis and guide more effective fertility treatments. Commercial adoption includes integration into major employer benefits programs such as Walmart via Kindbody coverage.

Therapeutic areas: Women's HealthMen's Health
Modalities: Diagnostic test (Epigenetic diagnostic)Device (at-home sample collection kit)Molecular diagnostics platform leveraging epigenetics and AI
Industry: Molecular Diagnostics

Drug pipeline

1 asset

SpermQT

Commercial

Indications: Male infertility

Partnerships

Kindbody (employee benefits program partner)Posterity Health (virtual male fertility center partnership for direct-to-consumer offering)

Beyond the preview

Go deeper on Path Fertility.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Path Fertility.

Explore the full profile